can glp 1 cause hyperthyroidism Dual Glucagon-Like Peptide-1 (GLP-1) and Glucose-Dependent Insulinotropic Polypeptide (GIP) Receptor Agonist-Associated Thyroiditis: A Case Report of Thyroid Dysfunction Following Tirzepatide Use The Thyroid Twist: How GLP-1

Developed by Eli Lilly, the once-daily pill targets appetite regulation and could expand access to obesity care

Patients collaborate closely with their surgical team during this preoperative phase to make sure they are maintaining their weight loss and fulfilling their nutritional needs

Continuing on to discontinuation rates we see another very interesting nugget that I have bolded below: Discontinuation rates due to adverse events were 12.2% and 18.2% with retatrutide 9 mg and 12 mg, respectively, compared to 4.0% with placebo

BioWorld - Saturday, July 18, 2026 Breaking News: Best of BioWorld Science: Q2See today's BioWorld Science Home Structural insights into small-molecule GLP-1 agonists To read the full story, subscribe or sign in

Examples include MySugr, Glucose Buddy, and One Drop, which allow logging of blood glucose readings, medication doses, meals, and physical activity in a single platform